GANC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.635800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.368400E-01
Normal-vs-Stage2
6.297800E-02
Normal-vs-Stage3
5.786400E-02
Normal-vs-Stage4
4.109000E-01
Stage1-vs-Stage2
6.826000E-01
Stage1-vs-Stage3
8.074000E-02
Stage1-vs-Stage4
8.460800E-01
Stage2-vs-Stage3
1.243040E-01
Stage2-vs-Stage4
5.747000E-01
Stage3-vs-Stage4
1.208040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.815800E-02
Normal-vs-AfricanAmerican
5.984500E-02
Normal-vs-Asian
1.689030E-01
Caucasian-vs-AfricanAmerican
4.045200E-01
Caucasian-vs-Asian
7.038800E-01
AfricanAmerican-vs-Asian
7.092400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.432300E-02
Normal-vs-Female
4.910000E-02
Male-vs-Female
6.946000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.447400E-01
Normal-vs-Age(41-60Yrs)
8.491800E-02
Normal-vs-Age(61-80Yrs)
3.947600E-02
Normal-vs-Age(81-100Yrs)
9.443500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.398000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.180000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.279800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.260410E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.898600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.625000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.753700E-02
Normal-vs-Daily Drinker
8.774000E-02
Normal-vs-Weekly Drinker
9.716500E-02
Normal-vs-Occasional Drinker
2.386400E-01
Normal-vs-Social Drinker
1.082830E-01
Non Drinker-vs-Daily Drinker
9.779000E-01
Non Drinker-vs-Weekly Drinker
6.960200E-01
Non Drinker-vs-Occasional Drinker
6.958800E-01
Non Drinker-vs-Social Drinker
3.174000E-01
Daily Drinker-vs-Weekly Drinker
7.104000E-01
Daily Drinker-vs-Occasional Drinker
6.874000E-01
Daily Drinker-vs-Social Drinker
3.780200E-01
Weekly Drinker-vs-Occasional Drinker
9.278400E-01
Weekly Drinker-vs-Social Drinker
2.490800E-01
Occasional Drinker-vs-Social Drinker
1.095370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.767500E-02
Normal-vs-Grade 2
1.275090E-03
Normal-vs-Grade 3
4.762800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.428500E-02
Grade 1-vs-Grade 3
1.545790E-02
Grade 1-vs-Grade 4
6.767500E-02
Grade 2-vs-Grade 3
4.590000E-01
Grade 2-vs-Grade 4
1.275090E-03
Grade 3-vs-Grade 4
4.762800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.053700E-02
Normal-vs-NonDiabetic
2.702000E-02
Diabetic-vs-NonDiabetic
5.491800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.543600E-02
Normal-vs-NoPancreatitis
3.086200E-02
Pancreatitis-vs-NoPancreatitis
8.129600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.719600E-02
Normal-vs-N1
6.410000E-02
N0-vs-N1
5.532400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.934650E-01
Normal-vs-TP53-NonMutant
1.407380E-01
TP53-Mutant-vs-TP53-NonMutant
1.208040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
